Here's the live share price of Advanced Enzyme Technologies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Advanced Enzyme Technologies has gained 8.20% CAGR. Over the past year, the corresponding return has been -26.58%.
Advanced Enzyme Technologies’s current P/E of 28.11x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Advanced Enzyme Technologies | 0.58 | 13.55 | 5.08 | 20.39 | -26.59 | 7.13 | 8.20 |
Sun Pharmaceutical Industries | 0.71 | -1.35 | -5.77 | -1.26 | -13.39 | 21.49 | 25.67 |
Divi's Laboratories | -3.10 | -0.27 | -10.47 | 8.36 | 9.95 | 17.55 | 13.59 |
Cipla | -1.34 | 3.62 | 3.12 | 6.52 | -4.54 | 13.53 | 16.45 |
Torrent Pharmaceuticals | -0.10 | -0.31 | 11.92 | 17.32 | 5.15 | 33.70 | 20.68 |
Dr. Reddy's Laboratories | 3.03 | 6.69 | -3.64 | 16.12 | -2.23 | 15.12 | 8.23 |
Mankind Pharma | 0.51 | 5.59 | 8.21 | 13.82 | 5.24 | 21.79 | 12.56 |
Zydus Lifesciences | 3.60 | 9.33 | 6.42 | 16.96 | -6.10 | 40.51 | 23.50 |
Lupin | 1.09 | 1.38 | -1.67 | -1.81 | -11.22 | 43.22 | 15.44 |
Abbott India | -4.19 | -5.34 | -1.29 | 1.97 | 4.93 | 19.89 | 13.59 |
Alkem Laboratories | 0.46 | 9.86 | 7.28 | 14.80 | -15.79 | 18.41 | 12.73 |
Aurobindo Pharma | 1.87 | 0.16 | -9.92 | -3.51 | -30.56 | 24.16 | 5.62 |
Glenmark Pharmaceuticals | 6.32 | 4.10 | 31.93 | 52.11 | 23.48 | 76.18 | 35.28 |
Biocon | 1.45 | 7.18 | 7.48 | 11.72 | -5.10 | 6.50 | -3.16 |
Laurus Labs | 1.79 | 7.16 | 33.72 | 59.52 | 75.73 | 17.67 | 29.21 |
GlaxoSmithKline Pharmaceuticals | 1.51 | 4.73 | -17.16 | 5.73 | -0.09 | 25.58 | 11.02 |
Anthem Biosciences | -0.32 | 8.86 | 12.34 | 12.34 | 12.34 | 3.95 | 2.35 |
Cohance Lifesciences | 9.78 | 5.44 | -2.28 | -14.25 | -16.74 | 27.71 | 23.72 |
Ipca Laboratories | -2.04 | -1.01 | -3.44 | -0.33 | -8.29 | 14.79 | 5.25 |
Ajanta Pharma | 1.33 | -2.18 | 0.56 | 2.93 | -24.37 | 23.26 | 20.81 |
Over the last one year, Advanced Enzyme Technologies has declined 26.59% compared to peers like Sun Pharmaceutical Industries (-13.39%), Divi's Laboratories (9.95%), Cipla (-4.54%). From a 5 year perspective, Advanced Enzyme Technologies has underperformed peers relative to Sun Pharmaceutical Industries (25.67%) and Divi's Laboratories (13.59%).
Day | SMA | EMA |
---|---|---|
5 | 340.66 | 341.14 |
10 | 325.75 | 335.88 |
20 | 316.57 | 329.87 |
50 | 326.19 | 324.88 |
100 | 314 | 322.36 |
200 | 321.09 | 331.53 |
In the latest quarter, Advanced Enzyme Technologies saw a drop in promoter holding to 43.06%, while DII stake increased to 8.45%, FII holding rose to 23.45%, and public shareholding moved down to 25.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 16,56,688 | 0.95 | 58.1 |
UTI MNC Fund | 10,37,821 | 1.28 | 36.4 |
ICICI Prudential ESG Exclusionary Strategy Fund | 8,72,022 | 2.03 | 30.58 |
HDFC Multi Cap Fund | 5,07,664 | 0.1 | 17.8 |
Bank of India Small Cap Fund | 3,60,000 | 0.65 | 12.63 |
Bank of India Flexi Cap Fund | 2,79,601 | 0.45 | 9.81 |
Bank of India ELSS Tax Saver | 2,62,089 | 0.66 | 9.19 |
Bank of India ELSS Tax Saver - Eco Plan | 2,62,089 | 0.66 | 9.19 |
ITI Pharma and Healthcare Fund | 51,175 | 0.76 | 1.79 |
Motilal Oswal BSE Healthcare ETF | 1,097 | 0.12 | 0.04 |
Date Time | Announcement |
---|---|
Aug 12, 2025, 12:18 AM IST | Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Aug 07, 2025, 12:16 AM IST | Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Aug 02, 2025, 8:54 PM IST | Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Aug 02, 2025, 8:49 PM IST | Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Investor Presentation |
Aug 02, 2025, 6:29 AM IST | Advanced Enzyme Tech - Unaudited Financial Results For The Quarter Ended June 30, 2025 |
Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 351.41 Cr. and Equity Capital is Rs. 22.38 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Advanced Enzyme Technologies is ₹341.05 as on Sep 10, 2025.
The Advanced Enzyme Technologies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Advanced Enzyme Technologies is ₹3,848.15 Cr as on Sep 10, 2025.
Today’s highest and lowest price of Advanced Enzyme Technologies are ₹348.90 and ₹340.00.
The 52-week high/low is the highest and lowest price at which Advanced Enzyme Technologies stock has traded in the past 52-week or nearly a year. The 52-week high of Advanced Enzyme Technologies is ₹571.15 and 52-week low of Advanced Enzyme Technologies is ₹257.85 as on Sep 10, 2025.
The Advanced Enzyme Technologies has shown returns of -0.39% over the past day, 13.57% for the past month, 5.1% over 3 months, -26.58% over 1 year, 7.13% across 3 years, and 8.2% over 5 years.
P/E ratio of and PB ratio of Advanced Enzyme Technologies are 28.11 and 2.87 on Sep 10, 2025. While the company gives a dividend yield of 1.51 per annum.